It's easy to think like this in hindsight given race have succeeded in getting rc220 to clinic. but the above q&a is in reference to that.
rc110 is viable without rc220 at a smaller scale, definitely not on the metrics of the triangle report.
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $205.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.18 | $93.21K | 78.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9255 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 1000 | 1 |
View Market Depth
| Last trade - 15.55pm 29/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |